B
BioNote Inc
KRX:377740
BioNote Inc
KRX:377740
Price:
5 460
KRW
-0.73%
Market Closed
Market Cap:
₩557.2B
Balance Sheet
Balance Sheet Decomposition
BioNote Inc
BioNote Inc
Balance Sheet Decomposition is not available for
BioNote Inc
BioNote Inc
Balance Sheet
BioNote Inc
BioNote Inc
Currency: KRW
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
6 576
|
123 080
|
418 612
|
681 067
|
147 395
|
107 341
|
|
| Cash |
0
|
0
|
0
|
0
|
15 453
|
22 081
|
|
| Cash Equivalents |
6 576
|
123 080
|
418 612
|
681 067
|
131 942
|
85 260
|
|
| Short-Term Investments |
1 147
|
80 531
|
70 000
|
39 722
|
252 590
|
307 484
|
|
| Total Receivables |
8 825
|
310 664
|
84 079
|
18 304
|
24 864
|
25 085
|
|
| Accounts Receivables |
8 825
|
310 577
|
83 961
|
17 821
|
23 964
|
24 744
|
|
| Other Receivables |
0
|
87
|
118
|
483
|
901
|
340
|
|
| Inventory |
7 757
|
53 053
|
64 859
|
79 038
|
30 683
|
25 029
|
|
| Other Current Assets |
333
|
6 100
|
3 159
|
6 705
|
945
|
762
|
|
| Total Current Assets |
24 638
|
573 428
|
640 709
|
824 836
|
456 478
|
465 700
|
|
| PP&E Net |
23 577
|
49 659
|
98 007
|
97 159
|
89 594
|
92 635
|
|
| PP&E Gross |
0
|
49 659
|
98 007
|
97 159
|
89 594
|
92 635
|
|
| Accumulated Depreciation |
0
|
8 515
|
12 199
|
17 363
|
31 473
|
35 174
|
|
| Intangible Assets |
305
|
250
|
354
|
1 589
|
4 750
|
3 638
|
|
| Goodwill |
0
|
0
|
5 512
|
5 512
|
5 512
|
678
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
942
|
1 383
|
|
| Long-Term Investments |
82 311
|
229 701
|
743 863
|
827 748
|
1 035 075
|
1 132 268
|
|
| Other Long-Term Assets |
0
|
401
|
422
|
157
|
491
|
855
|
|
| Other Assets |
0
|
0
|
5 512
|
5 512
|
5 512
|
678
|
|
| Total Assets |
130 831
N/A
|
853 440
+552%
|
1 488 867
+74%
|
1 757 002
+18%
|
1 592 842
-9%
|
1 697 157
+7%
|
|
| Liabilities | |||||||
| Accounts Payable |
2 316
|
29 670
|
5 412
|
3 302
|
3 520
|
2 541
|
|
| Accrued Liabilities |
0
|
10 936
|
10 034
|
5 199
|
1 999
|
1 991
|
|
| Short-Term Debt |
12 000
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
42
|
138
|
296
|
469
|
1 334
|
1 393
|
|
| Other Current Liabilities |
2 526
|
143 168
|
102 530
|
40 536
|
3 947
|
17 731
|
|
| Total Current Liabilities |
16 883
|
183 912
|
118 273
|
49 505
|
10 801
|
23 656
|
|
| Long-Term Debt |
50
|
207
|
474
|
893
|
3 594
|
2 538
|
|
| Deferred Income Tax |
3 291
|
30 593
|
97 517
|
106 300
|
21 652
|
34 817
|
|
| Other Liabilities |
30
|
32
|
99
|
151
|
219
|
374
|
|
| Total Liabilities |
20 255
N/A
|
214 744
+960%
|
216 363
+1%
|
156 850
-28%
|
36 266
-77%
|
61 384
+69%
|
|
| Equity | |||||||
| Common Stock |
2 924
|
2 924
|
46 778
|
50 938
|
51 028
|
51 028
|
|
| Retained Earnings |
51 991
|
580 217
|
1 207 900
|
1 466 034
|
1 392 828
|
1 427 616
|
|
| Additional Paid In Capital |
55 732
|
55 732
|
11 877
|
80 997
|
82 744
|
82 744
|
|
| Other Equity |
69
|
176
|
5 948
|
2 183
|
29 976
|
74 385
|
|
| Total Equity |
110 577
N/A
|
638 696
+478%
|
1 272 504
+99%
|
1 600 152
+26%
|
1 556 576
-3%
|
1 635 773
+5%
|
|
| Total Liabilities & Equity |
130 831
N/A
|
853 440
+552%
|
1 488 867
+74%
|
1 757 002
+18%
|
1 592 842
-9%
|
1 697 157
+7%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
102
|
102
|
102
|
102
|
102
|
101
|
|
Switch to:
Switch to:
See Also
Discover More
